ARMISTICE CAPITAL, LLC - 31 Dec 2024 SCHEDULE 13G/A Report for IRONWOOD PHARMACEUTICALS INC Class A common stock, $0.001 par value (IRWD)

Filing Manager: ARMISTICE CAPITAL, LLC
Reporting Manager: Armistice Capital, LLC
Security: IRONWOOD PHARMACEUTICALS INC Class A common stock, $0.001 par value
Symbol: IRWD
Shares outstanding: 159,932,432 shares
Disclosed Ownership: 9,468,000 shares
Ownership: 5.92%
Form type: SCHEDULE 13G/A
Filing time: 14 Feb 2025, 17:49:57 UTC
Date of event: 31 Dec 2024
Next filing: 15 May 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Armistice Capital, LLC	5.92%	9,468,000	0	9,468,000	/s/ Steven Boyd	Steven Boyd - Managing Member
Steven Boyd	5.92%	9,468,000	0	9,468,000	/s/ Steven Boyd	Steven Boyd